Devin B. Lowe

1.1k total citations
38 papers, 841 citations indexed

About

Devin B. Lowe is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Devin B. Lowe has authored 38 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 25 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Devin B. Lowe's work include Immunotherapy and Immune Responses (23 papers), Cancer Immunotherapy and Biomarkers (16 papers) and CAR-T cell therapy research (15 papers). Devin B. Lowe is often cited by papers focused on Immunotherapy and Immune Responses (23 papers), Cancer Immunotherapy and Biomarkers (16 papers) and CAR-T cell therapy research (15 papers). Devin B. Lowe collaborates with scholars based in United States, Netherlands and Italy. Devin B. Lowe's co-authors include Walter J. Storkus, Ninh M. La‐Beck, Saeed K Alzghari, Gary W. Jean, Cindy Huynh, Michael H. Shearer, Ronald C. Kennedy, Anamika Bose, Cynthia Jumper and Jennifer L. Taylor and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Cellular and Molecular Life Sciences.

In The Last Decade

Devin B. Lowe

38 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Devin B. Lowe United States	16	445	412	248	113	75	38	841
Luna Minute Spain	12	504 1.1×	529 1.3×	194 0.8×	82 0.7×	60 0.8×	16	858
Yann Godet France	19	591 1.3×	623 1.5×	359 1.4×	86 0.8×	106 1.4×	46	1.1k
Céline Colacios France	14	493 1.1×	525 1.3×	309 1.2×	58 0.5×	88 1.2×	25	1.0k
Yongpeng Gu United States	9	343 0.8×	257 0.6×	276 1.1×	163 1.4×	99 1.3×	12	755
Danielle M. Lussier United States	6	534 1.2×	518 1.3×	274 1.1×	199 1.8×	162 2.2×	8	990
Joseph S. Dolina United States	11	391 0.9×	527 1.3×	203 0.8×	87 0.8×	82 1.1×	16	805
Friedrich H. Schmitz-Winnenthal Germany	12	604 1.4×	271 0.7×	211 0.9×	67 0.6×	50 0.7×	22	953
Magalie Dosset France	16	490 1.1×	563 1.4×	268 1.1×	78 0.7×	67 0.9×	26	944
Yongsheng Wang China	20	545 1.2×	282 0.7×	310 1.3×	196 1.7×	119 1.6×	54	927
Anna Maria Trotta Italy	18	424 1.0×	301 0.7×	260 1.0×	173 1.5×	86 1.1×	35	1.1k

Countries citing papers authored by Devin B. Lowe

Since Specialization

Citations

This map shows the geographic impact of Devin B. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devin B. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devin B. Lowe more than expected).

Fields of papers citing papers by Devin B. Lowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devin B. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devin B. Lowe. The network helps show where Devin B. Lowe may publish in the future.

Co-authorship network of co-authors of Devin B. Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of Devin B. Lowe. A scholar is included among the top collaborators of Devin B. Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devin B. Lowe. Devin B. Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lawrence, Caryn, et al.. (2025). A PD-L1/CD3 Bispecific Antibody Enhances the Antitumor Effects of Regorafenib against Colon Cancer. Molecular Cancer Therapeutics. 24(8). 1240–1251. 2 indexed citations

Appiah, Duke, et al.. (2023). Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression. Frontiers in Immunology. 14. 1241949–1241949. 6 indexed citations

Appiah, Duke, et al.. (2023). Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection. OncoImmunology. 12(1). 2260620–2260620. 9 indexed citations

Lowe, Devin B., et al.. (2022). Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity. Seminars in Cancer Biology. 86(Pt 3). 981–996. 23 indexed citations

Nguyen, Hong-My, et al.. (2021). Pathogenetic Features and Current Management of Glioblastoma. Cancers. 13(4). 856–856. 48 indexed citations

Wood, Laurence M., et al.. (2020). Dendritic cell vaccine therapy for colorectal cancer. Pharmacological Research. 164. 105374–105374. 37 indexed citations

Lowe, Devin B., et al.. (2018). Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines. Journal of Immunological Methods. 464. 22–30. 4 indexed citations

Lowe, Devin B. & Ninh M. La‐Beck. (2016). Epithelial-mesenchymal transition as a potential biomarker for identifying responders to immune checkpoint inhibitor therapy in lung adenocarcinoma. Translational Cancer Research. 5(2). 208–210. 1 indexed citations

Weidanz, Jon A., et al.. (2015). Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology. Journal of Visualized Experiments. 3 indexed citations

10.

Lowe, Devin B., Jennifer L. Taylor, & Walter J. Storkus. (2014). Monitoring Antigen-Specific T Cell Responses Using Real-Time PCR. Methods in molecular biology. 1186. 65–74. 4 indexed citations

11.

Lowe, Devin B., Anamika Bose, Jennifer L. Taylor, et al.. (2014). Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma. OncoImmunology. 3(2). e27589–e27589. 38 indexed citations

12.

Chen, Li‐Mei, Jennifer L. Taylor, Devin B. Lowe, et al.. (2013). Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells. Cancer Gene Therapy. 20(8). 469–477. 27 indexed citations

13.

Qu, Yanyan, Lu Chen, Devin B. Lowe, Walter J. Storkus, & Jennifer L. Taylor. (2012). Combined Tbet and IL12 Gene Therapy Elicits and Recruits Superior Antitumor Immunity In Vivo. Molecular Therapy. 20(3). 644–651. 8 indexed citations

14.

Lowe, Devin B., et al.. (2012). Shock block for improved immunotherapy. OncoImmunology. 1(8). 1427–1429. 4 indexed citations

15.

Lowe, Devin B., et al.. (2010). Vaccines and Immunotherapeutics for the Treatment of Malignant Disease. Journal of Immunology Research. 2010(1). 697158–697158. 28 indexed citations

16.

Lowe, Devin B., et al.. (2010). Role of the Innate Immune Response and Tumor Immunity Associated with Simian Virus 40 Large Tumor Antigen. Journal of Virology. 84(19). 10121–10130. 9 indexed citations

17.

Chiriva‐Internati, Maurizio, Fabio Grizzi, Jon A. Weidanz, et al.. (2007). A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17. Journal of Immunological Methods. 321(1-2). 86–93. 25 indexed citations

18.

Lowe, Devin B., Michael H. Shearer, & Ronald C. Kennedy. (2006). DNA vaccines: Successes and limitations in cancer and infectious disease. Journal of Cellular Biochemistry. 98(2). 235–242. 33 indexed citations

19.

Lowe, Devin B., Michael H. Shearer, James Tarbox, et al.. (2004). In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization. Virology. 332(1). 28–37. 11 indexed citations

20.

Lowe, Devin B., et al.. (2004). Anti-idiotype responses abrogate anti-CD4?induced tolerance to a tumor-specific antigen and promote systemic tumor immunity. Cancer Immunology Immunotherapy. 53(11). 987–94. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact